Company / Free Cash Flow per Share
Intellia Therapeutics, Inc. Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$3.88
FY2025
5-year range
-$4.68 / -$3.59
FY2021-FY2025
Trend
-1.7%
vs FY2024
Sector context
#137 of 142
Health Care
What the data says
Among 142 Health Care companies, Intellia Therapeutics, Inc. is in the bottom 4% for free cash flow per share. Free Cash Flow per Share has fluctuated over the past 10 years, ranging from $-4.68 in FY2023 to $1.35 in FY2016.
Based on SEC 10-K filings.
-3.88 in FY2025.
Improved from $-4.68 to $-3.88 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 4% in Health CareTop 96% of 142This company -$3.88 Sector average $5.16
▼
-175.1% below sector average
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 1.7% year-over-year.
- Ranks #137 out of 142 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2016.
- Lowest free cash flow per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.14 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$3.88 | -1.7% |
| FY2024 | -$3.81 | +18.6% |
| FY2023 | -$4.68 | -0.6% |
| FY2022 | -$4.66 | -29.7% |
| FY2021 | -$3.59 | -236.9% |
| FY2020 | -$1.07 | +56.2% |
| FY2019 | -$2.43 | -52.5% |
| FY2018 | -$1.60 | +23.8% |
| FY2017 | -$2.09 | -255.3% |
| FY2016 | $1.35 | +107.6% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026